statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights PR Newswire TEL AVIV, Israel and RALEIGH...

RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights

RedHill Biopharma Ltd (RDHL) has released an update. RedHill Biopharma Ltd. has successfully closed a registered direct offering, raising $1.25 mil...

RedHill Biopharma Secures $1.25M in Direct Offering

RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price PR...

RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price

RedHill Announces New USPTO Patent Covering Talicia Through 2034 RedHill Announces New USPTO Patent Covering Talicia Through 2034 PR Newswire TEL AVIV, Israel and RALEIGH, N.C., March 11, 2024 U.S...

RedHill Announces New USPTO Patent Covering Talicia Through 2034

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

RedHill Biopharma's opaganib to be evaluated by BARDA, NIH

RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs PR Newswire TEL AVIV, Israel...

RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs

RedHill Biopharma's opaganib shows improved lung damage survival in publication

RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New...

RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication

RedHill Biopharma files to sell 10.6M American depositary shares for holders

RedHill Biopharma announces closing of $8M registered direct offering

RedHill Biopharma Ltd. develops medicines for gastrointestinal and infectious diseases. It operates through Commercial Operations, and the Research and Development segments. The Commercial Operations segment covers all areas relating to the commercial sales and is being performed by the subsidiary in the U.S. The Research and Development segment includes the study and licensing of therapeutic candidates. Its products include Talicia, Movantik, and Aemcolo. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.

Volume	220,476.00
52-Wk High	$3.28
52-Wk Low	$0.257

RDHL RedHill Biopharma Ltd.

About

Feed

News

Sentiment

Fundamentals